草地贪夜蛾热激蛋白基因SfHsp90的克隆及在高低温和UV-A胁迫下的表达分析

【目的】本研究旨在探索草地贪夜蛾Spodoptera frugiperda响应高低温和UV-A胁迫的分子机制。【方法】通过RT-PCR技术克隆草地贪夜蛾热激蛋白基因Hsp90,利用生物信息学方法分析其序列特征;采用RT-qPCR技术检测草地贪夜蛾Hsp90基因在不同发育阶段(卵、1-6龄幼虫、蛹和成虫)、成虫不同组织(去除触角和复眼的头、胸、腹、触角、复眼、足、翅、中肠、精巢和卵巢)及在不同时长(0, 30, 60, 90, 120和150 min)高温(36℃)、低温(4℃)和UV-A胁迫下成虫中的相对表达量。【结果】克隆获得草地贪夜蛾Hsp90基因,命名为SfHsp90(GenBank登录号:MN832694),该基因开放阅读框(ORF)长2 154 bp,编码717个氨基酸,编码蛋白质相对分子量为82.52 kD,等电点(pI)为5.01,C末端序列含保守基序EEVD,说明该蛋白为胞质型热激蛋白。系统进化分析结果表明,昆虫Hsp90高度保守。发育表达模式显示SfHsp90在草地贪夜蛾1龄幼虫中表达量最高;组织表达模式显示,SfHsp90在草地贪夜蛾雌雄成虫的触角、复眼和去除触角和复眼的头中的表达量显著高于在其他组织中的。高低温胁迫对草地贪夜蛾SfHsp90表达具有明显的诱导作用,36℃胁迫下,SfHsp90表达量显著高于对照,且随着处理时间的延长,在雄成虫中表达量先上升后下降,在60 min时达到最高值,在雌成虫中表达量随处理时间延长逐渐升高;4℃胁迫下,在雄成虫中表达量随着处理时间的延长先上升后下降,在30 min时表达量达到峰值,在雌成虫中表达量随着处理时间延长逐渐上升;随着UV-A照射时间的延长,在雌雄成虫中表达量先上升后下降,90 min时在雄成虫中表达量达到最高值,60 min时在雌成虫中表达量达到最高值。【结论】草地贪夜蛾SfHsp90基因在高低温和UV-A胁迫下的差异表达说明该基因在草地贪夜蛾响应环境胁迫的分子机制中发挥重要作用。     

草地贪夜蛾海藻糖合成酶基因的克隆、时空表达谱及对温度胁迫的响应

【目的】本研究旨在通过克隆草地贪夜蛾Spodoptera frugiperda的海藻糖合成酶(trehalose-6-phosphate synthase)基因SfTPS,分析其在草地贪夜蛾不同发育阶段、不同组织中的表达水平及不同温度胁迫时5龄幼虫中的相对表达量,为进一步探究TPS在草地贪夜蛾生长发育及抗逆应激反应中的功能奠定基础。【方法】运用RT-PCR技术克隆草地贪夜蛾SfTPS的全长编码区,并进行生物信息学分析。运用RT-qPCR技术检测SfTPS在草地贪夜蛾不同发育阶段(卵、1-6龄幼虫、蛹和成虫)、5龄幼虫不同组织(体壁、中肠和脂肪体)中和经短期(2, 4和8 h)高(35℃)低温(10℃)胁迫后5龄幼虫中的表达变化。【结果】克隆获得2 571 bp的草地贪夜蛾TPS cDNA序列,命名为SfTPS(GenBank登录号： MT920672),全长开放阅读框(ORF)长2 481 bp,编码的826个氨基酸具有TPS和TPP两个保守结构域。同源比对和系统进化分析表明,昆虫TPS蛋白具有较高的保守性,SfTPS与斜纹夜蛾S. litura的TPS亲缘关系最近,序列一致性达到99.15%。SfTPS中α-螺旋、β-折叠和无规则卷曲占比分别为38.14%, 12.23%和48.55%;SfTPS的三级结构为同源二聚体。RT-qPCR结果表明,SfTPS在草地贪夜蛾卵期和1-5龄幼虫期低表达,在6龄幼虫期、蛹期和成虫期高表达,且草地贪夜蛾变态前后SfTPS的表达量变化较大。组织分布结果显示,SfTPS在5龄幼虫脂肪体中表达量最高。草地贪夜蛾5龄幼虫经2~8 h低温(10℃)和高温(35℃)胁迫后,SfTPS的相对表达量显著高于对照(25℃),分别为对照的4.43~9.34和2.50~6.03倍。【结论】SfTPS基因在草地贪夜蛾生长发育过程及抵御高低温度胁迫中可能具有重要作用。     

三种杀虫剂亚致死剂量对草地贪夜蛾细胞色素P450基因表达的影响

【目的】为明确杀虫剂亚致死剂量对草地贪夜蛾Spodoptera frugiperda细胞色素P450基因表达的影响。【方法】本研究采用叶片浸渍法测定了3种杀虫剂[氯虫苯甲酰胺、甲氨基阿维菌素苯甲酸盐和苏云金杆菌Bacillus thuringiensis(Bt)]对草地贪夜蛾2龄幼虫的毒力,以及通过实时荧光定量PCR(real-time quantitative PCR, RT-qPCR)技术测定了这3种杀虫剂亚致死剂量(LC_(10))处理后48 h时草地贪夜蛾2龄幼虫16个P450基因的表达量。【结果】氯虫苯甲酰胺、甲氨基阿维菌素苯甲酸盐和Bt对草地贪夜蛾2龄幼虫的LC_(10)值分别为0.931, 0.283和1 089.688 mg/L。2龄幼虫受LC_(10)氯虫苯甲酰胺胁迫后,13个P450基因(CYP4G75,CYP6AB12,CYP6B50,CYP321A7,CY321A8,CYP321A9,CYP321A10,CYP321B1,CYP337B5,CYP9A59,CYP9A58,CYP6AE44及CYP6AE43)表达上调,其中CYP6AE44表达量为对照的34.60倍;2龄幼虫受LC_(10)甲维盐胁迫后,11个P450基因(CYP4G75,CYP6AB12,CYP321A7,CY321A8,CYP321A9,CYP321A10,CYP321B1,CYP337B5,CYP9A58,CYP6AE44及CYP6AE43)表达上调,其中CYP321B1表达量为对照的28.70倍;2龄幼虫受LC_(10)Bt胁迫后,11个P450基因(CYP4G75,CYP6AB12,CYP6AN4,CYP321A7,CY321A8,CYP321A9,CYP321A10,CYP321B1,CYP337B5,CYP6AE44及CYP6AE43)表达上调,其中CYP6AE44表达量为对照的40.80倍。【结论】草地贪夜蛾2龄幼虫的多个P450基因受这3种杀虫剂亚致死剂量处理后表达上调,其中CYP4G75,CYP6AB12,CYP321A7,CY321A8,CYP321A9,CYP321A10,CYP321B1,CYP321B5,CYP6AE44及CYP6AE43均能被这3种杀虫剂诱导表达。     

氯吡格雷对大鼠肝药物酶CYP3A4 和CYP1A2 表达的影响

目的：氯吡格雷主要由CYP3A4 催化使其激活,CYP1A2 也参与氯吡格雷活化。关于氯吡格雷对肝微粒体酶的影响国内外 文献报道不多,因此本实验通过检测肝细胞色素氧化酶CYP3A4 和CYP1A2 的表达,探讨氯吡格雷对大鼠肝药物酶的影 响。方法：生理盐水为对照组,氯吡格雷设高、中、低三个剂量组（27,13.5,6.75mg/kg/d）,雄性健康大鼠连续灌胃给药7天,脱臼处 死,取肝组织,通过western blot法检测大鼠肝脏CYP3A4 和CYP1A2 蛋白表达情况。结果：1）、氯吡格雷抑制大鼠CYP3A4 蛋白 表达,氯吡格雷高中低剂量组分别比生理盐水组大鼠CYP3A4 蛋白表达量降低（P<0.05）;氯吡格雷低中高剂量组间进行比较,大 鼠CYP3A4 蛋白表达量呈梯度减少（P<0.05）;2）、氯吡格雷抑制大鼠CYP1A2 蛋白表达,氯吡格雷高中低剂量组分别比生理盐水 组大鼠CYP1A2 蛋白表达量降低（P<0.05）,氯吡格雷低中高剂量组间进行比较,大鼠CYP1A2 蛋白表达量呈梯度减少（P<0.05）。 结论：氯吡格雷使肝细胞色素氧化酶CYP3A4 和CYP1A2 的表达量减少,因此氯吡格雷高、中、低3 个剂量组均不同程度的抑制 大鼠肝脏CYP3A4 和CYP1A2 的表达,提示当氯吡格雷与某些主要经CYP3A4 和CYP1A2 代谢的药物合用时,发生代谢性相关 作用的可能性大。     

草地贪夜蛾解毒代谢相关基因家族的进化分析

近年来草地贪夜蛾Spodoptera frugiperda在世界各地猖獗为害,其寄主范围广,且已对多种化学药剂和转Bt玉米产生抗性。本文对包括草地贪夜蛾在内的14种昆虫进行了解毒代谢相关基因家族的注释,在草地贪夜蛾中发现了152个细胞色素P450(cytochrome p450,P450)、92个ABC转运蛋白(ATP-binding cassette transporter,ABC transporter)、44个谷胱甘肽转移酶(glutathione s-transferase,GST)以及39个尿苷二磷酸葡萄糖醛酸转移酶(UDP-glucuronosyl-transferase,UGT)。与其他鳞翅目物种相比,草地贪夜蛾的P450和GST基因数量最多,其中152个P450基因可被归类至Mito、CYP2、CYP3和CYP4四个簇中;Mito和CYP2簇的P450基因总数与家蚕Bombyx mori相近,但CYP3和CYP4簇的P450基因明显多于家蚕,进化分析结果显示CYP3和CYP4簇的P450基因发生了明显的扩增;与家蚕P450基因的共线性分析发现草地贪夜蛾89个P450基因在其基因组上呈簇分布并发生了簇的扩增;与家蚕相比,GST和ABC转运蛋白家族基因的数量明显增多。UGT基因家族没有明显增加,但在基因进化分析中有成簇现象,表明可能存在近期的扩增事件。本研究首次从基因组水平鉴定了草地贪夜蛾解毒代谢相关基因家族,对理解草地贪夜蛾的生物学特性及抗性的形成具有重要指导意义。     

亚洲玉米螟中stuxnet基因的时空表达与功能分析

[目的]本研究旨在鉴定亚洲玉米螟Ostrinia furnacalis中stuxnet (stx)同源基因Ofstuxnet(Ofstx),进一步明确ofstx基因的功能,探索基于表观遗传调控的害虫防治新策略.[方法]基于反转录技术获取亚洲玉米螟ofstx基因的全长cDNA序列,进行cDNA全长测序,分析其生物学信息;分别提取亚洲玉米螟不同发育阶段(3-5龄期幼虫)及不同组织(头、中肠、脂肪体)中RNA,并通过RT-qPCR技术检测ofstx基因在亚洲玉米螟不同发育阶段及不同组织中的相对表达量.[结果]亚洲玉米螟ofstx基因全长2112 bp,编码蛋白质含703个氨基酸,预测分子量76.98 ku,等电点8.30.比对其它物种Stx同源蛋白氨基酸序列发现其都含有UBL保守结构域.系统发育树分析发现与草地贪夜蛾Spodoptera frugiperda所属的夜蛾科同源性较高.qPCR结果显示ofStx在脑内相对表达量最高,在3-5龄幼虫中,4龄幼虫体内总体表达量最高.[结论]ofstx基因主要在亚洲玉米螟脑内表达,幼虫阶段的第4龄期相较第3、第5龄期相对表达高,可能参与调控昆虫生长发育,具体功能有待进一步研究.     

草地贪夜蛾烟碱型乙酰胆碱受体α6和α7亚基基因克隆及其对乙基多杀菌素胁迫的响应

【目的】烟碱型乙酰胆碱受体(nicotinic acetylcholine receptors,nAchRs)作为昆虫中枢神经系统中重要的神经递质受体,是乙基多杀菌素的重要靶标。本研究旨在克隆草地贪夜蛾Spodopterafrugiperda nAchR基因,并探析其对乙基多杀菌素胁迫的响应。【方法】基于前期草地贪夜蛾转录组数据,采用RT-PCR和RACE分别克隆草地贪夜蛾nAchR α6和α7亚基基因;乙基多杀菌素(0.400 mg/L)处理草地贪夜蛾3龄幼虫48 h后,采用RT-qPCR技术检测nAchR α6和α7亚基基因的表达量的变化。【结果】nAchR α6亚基基因(GenBank登录号: MT951400)开放阅读框长1 506 bp,编码502个氨基酸,并具有跨膜区与信号肽;nAchRs α7亚基基因(GenBank登录号: MW557608)开放阅读框长1 524 bp,编码508个氨基酸,并具有跨膜区与信号肽。根据氨基酸多序列比对分析,草地贪夜蛾nAchR亚基α6和α7具有烟碱性乙酰胆碱受体α家族典型特征。0.400 mg/L乙基多杀菌素胁迫48 h后,草地贪夜蛾3龄幼虫nAchR α6亚基基因表达量显著增加,而nAchR α7亚基基因表达量无显著性变化。【结论】乙基多杀菌素可能作用于草地贪夜蛾的nAchR α6亚基。本研究为深入研究草地贪夜蛾对乙基多杀菌素的靶标抗性机制奠定了初步基础。     

氯吡格雷对大鼠肝药物酶CYP3A4和CYP1A2表达的影响

目的：氯吡格雷主要由CYP3A4催化使其激活,CYPlA2也参与氯吡格雷活化。关于氯吡格雷对肝微粒体酶的影响国内外文献报道不多,因此本实验通过检测肝细胞色素氧化酶CYP3A4和CYPlA2的表达,探讨氯吡格雷对大鼠肝药物酶的影响。方法：生理盐水为对照组,氯吡格雷设高、中、低三个剂量组（27,13．5,6．75mg／kg／d）,雄性健康大鼠连续灌胃给药7天,脱臼处死,取肝组织,通过westernblot法检测大鼠肝脏CYP3A4和CYPlA2蛋白表达情况。结果：1）、氯吡格雷抑制大鼠CYP3A4蛋白表达,氯吡格雷高中低剂量组分别比生理盐水组大鼠CYP3A4蛋白表达量降低（P〈0．05）;氯吡格雷低中高剂量组间进行比较,大鼠CYP3A4蛋白表达量呈梯度减少（P〈0．05）;2）、氯吡格雷抑制大鼠CYPlA2蛋白表达,氯吡格雷高中低剂量组分别比生理盐水组大鼠CYPlA2蛋白表达量降低（P〈0．05）,氯吡格雷低中高剂量组间进行比较,大鼠CYPlA2蛋白表达量呈梯度减少（P〈0．05）。结论：氯吡格雷使肝细胞色素氧化酶CYP3A4和CYPlA2的表达量减少,因此氯吡格雷高、中、低3个剂量组均不同程度的抑制大鼠肝脏CYP3A4和CYPlA2的表达,提示当氯吡格雷与某些主要经CYP3A4和CYPlA2代谢的药物合用时,发生代谢性相关作用的可能性大。     

斜纹夜蛾蜕皮激素合成通路相关CYP450基因的鉴定及表达分析

【目的】本研究旨在探讨蜕皮激素合成通路相关CYP450基因的表达规律,为害虫防治提供潜在的作用靶标。【方法】以家蚕Bombyx mori CYP450基因为查询序列,通过同源比对的方法从斜纹夜蛾Spodoptera litura基因组中鉴定蜕皮激素合成代谢通路中的CYP450基因,并构建其系统进化树;采用qPCR法检测鉴定的CYP450基因在斜纹夜蛾不同发育阶段(6龄幼虫、预蛹和蛹)、这3个发育阶段的不同组织(中肠、表皮和脂肪体)以及4龄幼虫取食不同寄主植物(辣椒Capsicum annuum、黄瓜Cucumis sativus、番薯Ipomoea batatas和花生Arachis hypogaea)叶片后5龄幼虫中肠中的表达量,计算4龄幼虫取食不同寄主植物叶片后发育至蛹的历期;应用PITA, miRanda, microTar和RNAhybrid 4种软件,预测调控鉴定的CYP450基因的微小RNA (miRNA)。【结果】鉴定到斜纹夜蛾蜕皮激素合成通路相关的6个直系同源CYP450基因CYP307A1, CYP306A1, CYP302A1, CYP315A1, CYP314A1和CYP18A1;系统进化树显示,斜纹夜蛾这6个CYP450基因分别归属于CYP2和线粒体CYP两个亚家族。CYP306A1, CYP314A1和CYP18A1分别在6龄幼虫、预蛹和蛹期具有最高的表达量,并且分别在6龄幼虫中肠、预蛹脂肪体和蛹表皮中表达量最高。相比取食人工饲料的对照组,4龄幼虫取食番薯和花生叶片后斜纹夜蛾4龄幼虫发育至蛹的历期显著延长, CYP306A1在5龄幼虫中肠中的表达量显著上调。在CYP307A1,CYP315A1, CYP314A1和CYP18A1上鉴定出了多种miRNA结合位点。【结论】蜕皮激素合成代谢通路中,CYP306A1,CYP314A1和CYP18A1可能分别在斜纹夜蛾幼虫、预蛹和蛹期起着关键的调控作用,同时也参与宿主植物次生代谢产物的解毒代谢,并且受到miRNA的严密调控。研究结果不仅有助于深入理解昆虫变态发育调控的复杂机制,还为将来的害虫防治提供了潜在的作用靶标,有利于斜纹夜蛾等害虫的可持续治理。     

菘蓝CYP83B1基因的克隆与表达分析

对菘蓝（Isatis indigotica Fort.）CYP83B1基因进行了克隆与表达模式分析。结果显示,IiCYP83B1基因全长为1652 bp,包含2个外显子和1个内含子;cDNA全长为1500 bp,编码499个氨基酸。IiCYP83B1编码的蛋白没有跨膜结构域和信号肽,主要定位于内质网膜,属于亲水性蛋白,二级结构主要由无规则卷曲螺旋和α-螺旋组成,与萝卜（Raphanus sativus Linn.）、欧洲油菜（Brassica napus L.）、甘蓝（Brassica oleracea L.）和芜菁（Brassica rapa L.）等植物的CYP83B1蛋白具有较高的同源性。qRT-PCR分析结果表明,IiCYP83B1基因在菘蓝的根、茎、叶、花和果中均有表达,且以叶中的表达量最高;在幼苗期、生长期和花期稳定表达且均显著高于萌芽期;茉莉酸甲酯（methyl jasmonate,MeJA）和葡萄糖（glucose,Glu）能够显著促进该基因的表达,而低温（4℃）和水杨酸（salicylic acid,SA）处理对其表达具有一定的抑制效应。本研究结果可为进一步探讨IiCYP83B1基因的功能提供参考。     

Leukotriene B4 omega-side chain hydroxylation by CYP4F5 and CYP4F6

Leukotriene B(4) (LTB(4)) is a lipid mediator that plays an important role in inflammation. Metabolism of LTB(4) by cytochrome P450 (CYP) enzymes belonging to the CYP4F subfamily is considered to be of importance for the regulation of inflammation. This study investigates LTB(4) metabolism by recombinant rat CYP4F5 and CYP4F6 expressed in a yeast system and by microsomes isolated from rat organs expressing CYP4F mRNA. CYP4F6 was found to convert LTB(4) into 19-hydoxy- and 18-hydroxy-LTB(4) with an apparent K(m) of 26 microM, and CYP4F5 was found to convert LTB(4) primarily into 18-hydroxy-LTB(4) with an apparent K(m) of 9.7 microM. The rate of formation of 18-hydroxy-LTB(4) by CYP4F5 was surprisingly high. At a substrate concentration of 30 microM, the rate of formation was about 15 nmol/min/mg microsomal protein, approximately 30 times faster than the reaction catalyzed by CYP4F6. Analysis of LTB(4) metabolism by microsomes isolated from various tissues from the rat suggests that CYP4F5 and CYP4F6 are active in the lung and to some extent in the brain, kidney, and testis. CYP4F5 and CYP4F6, due to their capacities to metabolize LTB(4), may play important roles in modulating inflammatory response in these organs.     

Identification of multiple cytochrome P450 genes belonging to the CYP4 family in Xenopus laevis: cDNA cloning of CYP4F42 and CYP4V4

In order to obtain cDNA clones coding for CYP4 proteins in frog Xenopus laevis, degenerate primers were designed utilizing the conserved sequences of known CYP4s and were used to amplify partial cDNA fragments from liver mRNA. Five new CYP genes were identified. Three of these genes, XL-1, -2 and -3, were assigned to the CYP4T subfamily found previously in fish and amphibians. The other two genes, XL-4 and XL-5, were quite similar to CYP4F and CYP4V subfamilies, respectively. Subsequently, two full-length cDNA clones corresponding to XL-4 and XL-5 were isolated and characterized. The resultant cDNAs, designated as CYP4F42 and CYP4V4, had open reading frames encoding proteins of 528 and 520 residues, respectively. RT-PCR analysis indicated that the expression of CYP4F42 was limited to the liver, kidney, intestine and brain. In contrast, CYP4V4 mRNA was expressed ubiquitously.     

Sugar-mediated lyoprotection of purified human CYP3A4 and CYP2D6

P450 enzymes are of great interest for drug metabolism and as potential biocatalysts. Like most P450s, purified CYP3A4 is normally handled and stored in solution because lyophilization greatly reduces its activity. We show here that colyophilization of this enzyme with sucrose or trehalose, but not mannitol, crown ethers or cyclodextrins, allow recovery of full enzymatic activity after rehydration. Sorbitol was almost as efficient, with 85% retention of the original activity. We also show that similar protection is observed through colyophilization of CYP2D6 with trehalose. This procedure should greatly facilitate handling, storage, or use of these enzymes in anhydrous media.     

Molecular basis for the omega-regiospecificity of the CYP4A2 and CYP4A3 fatty acid hydroxylases

The CYP4A fatty acid omega-hydroxylases are involved in important physiological processes such as the regulation of vascular pressure. A previous study of chimeras of the rat CYP4A2 and CYP4A3 enzymes established that the regiochemistry of fatty acid hydroxylation is determined by the first 119 amino acid residues (Hoch, U., Zhang. Z. P., Kroetz, D. L., and Ortiz de Montellano, P. R. (2000) Arch. Biochem. Biophys. 373, 63-71). The role of the individual amino acid differences in this region has therefore been examined by site-specific mutagenesis to determine which residues actually control the omega- versus (omega-1)-regiospecificity. The results indicate that regiospecificity is controlled by the presence or absence of a three-residue insert (Ser-114, Gly-115, Ile-116) in CYP4A3 and by the residue at position 119 (CYP4A3 numbering). Furthermore, analysis of the absolute stereochemistry of the 11-hydroxylauric acid product indicates that this stereochemistry is not very sensitive to changes in the residues that line the substrate access channel. These results define a model of the specificity determinants of an important class of cytochrome P450 enzymes.     

Characterization of the CYP4A11 gene,a second CYP4A gene in humans

Comparison between the cDNA sequence of CYP4A11 and that deduced from a published genomic clone suggested the presence of an additional CYP4A gene in humans, CYP4A22. PCR amplification of genomic DNA yielded overlapping clones covering 13kb of genomic DNA and extending from 1003bp upstream from CYP4A11 translation initiation to 135bp upstream of the mRNA polyadenylation signal. Sequence and Southern blot analysis showed the presence in humans of two highly homologous CYP4A genes, CYP4A11 and CYP4A22. These two genes share 96% sequence identity and have similar intron/exon sizes and distribution. Short nucleotide insertions (< or =10bp) in introns 1, 3, 9, and 11, and deletions (< or =18bp) in introns 4, 6, and 11 differentiate the two genes. RT-PCR amplification of human kidney RNA followed by restriction fragment analysis showed that CYP4A11 is the predominant isoform expressed in kidney.     

CYP3A4 and CYP2D6 inhibitory activities of Indonesian medicinal plants

Thirty samples of Indonesian medicinal plants were analyzed for their capacity to inhibit in vitro metabolism by human cytochrome P450 3A4 (CYP3A4) and CYP2D6 with a radiometric assay. The MeOH-soluble fractions of 25 samples, prepared from water extracts, demonstrated inhibitory activity more than 50% on the metabolism mediated by CYP3A4, and 21 samples on the metabolism mediated by CYP2D6. Among the MeOH-soluble fractions, Piper nigrum leaf showed the highest inhibitory activity against CYP3A4 (91.7%), and Punica granatum against CYP2D6 (98.1%). The water extracts of which MeOH-soluble fraction showed inhibitory activity more than 70% were fractionated with EtOAc. From the EtOAc-soluble fractions, Curcuma heyneana (67.0%), Pi. cubeba (75.0%), Pi. nigrum fruit (84.0%), Pi. nigrum leaf (85.8%), and Zingiber aromaticum (75.3%) demonstrated inhibitory activity more than 50% on the metabolism mediated by CYP3A4, but only Pi. nigrum fruit (72.8%) and Pi. nigrum leaf (69.1%) showed strong inhibitory activity against CYP2D6. For samples that showed more than 70% inhibition, their IC(50) values were determined. The most potent inhibitory activity against CYP3A4 (IC(50) value of 25 microg/ml) was found for the extract of Pi. nigrum leaf, while that of Catharanthus roseus showed the most potent inhibitory effect against CYP2D6 (IC(50) value of 11 microg/ml). These results should indicate once more the possibility of potential medicinal plant-drug interactions.     

Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians

Potential causes of variability in drug response include intrinsic factors such as ethnicity and genetic differences in the expression of enzymes that metabolize drugs, such as those from Cytochrome P450 (CYPs) superfamily. Pharmacogenetic studies search for genetic differences between populations since relevant alleles occur with varying frequencies among different ethnic populations. The Brazilian population is one of the most heterogeneous in the world, resulting from multiethnic admixture of Amerindians, Europeans, and Africans across centuries. Since the knowledge of CYP allele frequency distributions is relevant to pharmacogenetic strategies and these data are scarce in the Brazilian population, this study aimed to describe genotype and allele distributions of 15 single nucleotide polymorphisms (SNPs) at CYP 1A2, 2C19, 3A4, and 3A5 genes in African and European descents from South Brazil. A sample of 179 healthy individuals of European and African ancestry was genotyped by the MassARRAY SNP genotyping system. CYP3A5*3, CYP1A2*1F, CYP3A4*1B, and CYP2C19*2 were the most frequent alleles found in our sample. Significant differences in genotype and allelic distribution between African and European descents were observed for CYP3A4 and CYP3A5 genes. CYP3A4*1B was observed in higher frequency in African descents (0.379) than in European descents (0.098), and European descents showed higher frequency of CYP3A5*3 (0.810) than African descents (0.523). Our results indicate that only a few polymorphisms would have impact in pharmacogenetic testing in South Brazilians. Further studies with larger sample sizes are required also among other Brazilian regions.     

CYP3A4基础与临床研究进展

细胞色素P4503A4(CYP3A4)是存在人类肝脏及肠道中的一种主要的细胞色素CYP450酶,约占成人肝脏CYP450酶总量的25%左右。临床中约有50%的药物是通过其代谢,并且其基因位点突变也与其多种疾病相关,知晓CYP3A4的表达水平和不同功能的遗传学基础,无论是对疾病的发病基础、临床药物的应用,会带来前所未有的启发,在药物应用过程中,通过对基因组学的认识,从而可以在基因层面了解个体代谢差异产生的原因,调整药物用量,提高疗效,最终使药物副作用降到最低限。目前对CYP3A4的研究渐趋于成熟,已逐渐阐明了其药物间相互作用的机制,它能够被多种药物竞争性抑制或者诱导,并受到某些蛋白受体的调控影响,可改变药物的药代动力学,增强或降低药效,造成个体用药差异,这也是造成药物间相互作用的重要原因。然而CYP3A4基因多态性与基因导向治疗关系,还有待进一步深入研究。该文对CYP3A4基因多态性、分布以及与临床疾病及用药的研究现状作一综述。